Literature DB >> 17361080

Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes.

Albrecht Stenzinger1, Dietmar Schreiner, Thorsten Pfeiffer, Claudia Tag, Hans Werner Hofer, Monika Wimmer.   

Abstract

The novel protein PTPIP51 (protein tyrosine phosphatase-interacting protein 51), which has been found to interact with protein tyrosine phosphatases of the PTP1B/TcPTP subfamily, is expressed in all suprabasal layers of human epidermis. Hence, a human keratinocyte cell line (HaCaT) grown on culture slides was used as a simplified model system to study the influence of hormonal agents on the regulation of PTPIP51 expression. Results were obtained by immunocytochemistry and subsequent statistical analysis. Additionally, immunoblotting was performed to detect the possible occurrence of distinct molecular weight forms as described previously. Subcellular localization of PTPIP51 protein was analyzed by specific staining of cellular organelles. HaCaT cells were subjected to treatment with factors that are crucial for the regulation of proliferation and differentiation of keratinocytes in human epidermis: epidermal growth factor (EGF), transforming growth factor-beta(TGF-beta), retinoic acid (RA) and 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)]. Epidermal growth factor receptor (EGFR) expressed in HaCaT cells was inhibited by PD153035. Only about 35% of untreated HaCaT cells were immunoreactive for the PTPIP51 protein. Whereas cells treated with increasing concentrations of 1,25 (OH)(2)D(3) showed a stepwise numerical increase of PTPIP51-positive cells, treatment with RA did not influence the number of PTPIP51-positive cells except when supraphysiological concentrations were applied. Concentration-dependent increase of cells stained positive for PTPIP51 was also observed when HaCaT cells were subjected to EGF treatment. Additional treatment of these cells with PD153035 led to a slight decrease in the fraction of PTPIP51-positive cells, which was not statistically significant. Immunoblotting results suggest a specific pattern of different molecular weight forms of PTPIP51 being expressed in HaCaT cells. Subcellular analysis revealed an association of the protein with mitochondria in nonconfluent cells, whereas confluent cells lack such correlation. The intracellular distribution of PTPIP51 resembled the localization of its interacting partner TcPTP. Furthermore, PTPIP51 was found to be present in both the nucleus and cytoplasm of HaCaT cells. In summary, the results indicate a possible association of PTPIP51 expression with differentiation as well as with apoptosis of keratinocytes. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17361080     DOI: 10.1159/000098949

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  8 in total

1.  Protein tyrosine phosphatase interacting protein 51 (PTPIP51) mRNA expression and localization and its in vitro interacting partner protein tyrosine phosphatase 1B (PTP1B) in human placenta of the first, second, and third trimester.

Authors:  Albrecht Stenzinger; David Märker; Philipp Koch; Jens Hoffmann; Nelli Baal; Klaus Steger; Monika Wimmer
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

Review 2.  Emerging drugs for the treatment of diabetic ulcers.

Authors:  Francesco Tecilazich; Thanh L Dinh; Aristidis Veves
Journal:  Expert Opin Emerg Drugs       Date:  2013-05-21       Impact factor: 4.191

3.  Expression of the novel protein PTPIP51 in rat liver: an immunohistochemical study.

Authors:  Albrecht Stenzinger; Dietmar Schreiner; Claudia Tag; Monika Wimmer
Journal:  Histochem Cell Biol       Date:  2007-06-06       Impact factor: 4.304

4.  Differentiation-dependent PTPIP51 expression in human skeletal muscle cell culture.

Authors:  Justus Barop; Heinrich Sauer; Klaus Steger; Monika Wimmer
Journal:  J Histochem Cytochem       Date:  2009-01-05       Impact factor: 2.479

5.  Expression of PTPIP51 during mouse eye development.

Authors:  David Maerker; Albrecht Stenzinger; Dietmar Schreiner; Claudia Tag; Monika Wimmer
Journal:  Histochem Cell Biol       Date:  2007-12-15       Impact factor: 4.304

6.  PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway.

Authors:  Alexander Brobeil; Fabian Kämmerer; Claudia Tag; Klaus Steger; Stefan Gattenlöhner; Monika Wimmer
Journal:  Biomolecules       Date:  2015-04-16

7.  Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.

Authors:  Eric Dietel; Alexander Brobeil; Lucas Delventhal; Claudia Tag; Stefan Gattenlöhner; Monika Wimmer
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

8.  The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma.

Authors:  P Koch; A Stenzinger; M Viard; D Märker; P Mayser; M Nilles; D Schreiner; K Steger; M Wimmer
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.